Richard, a biostatistician, has been a Pfizer colleague for over eight years. In 2007 Richard joined a group dedicated to providing biostatistics support to Health Economics and Outcomes Research. He believes that "Sharing best practices from my Pfizer experience with my alliance partner colleagues will enable them to better utilize scarce resources in combating infectious diseases in their region."
Richard will be serving with the Infectious Diseases Institute (IDI) in Kampala, Uganda. From 2012-2013, Global Health Fellows will work with the IDI research team to assess and strengthen their capacity to run Phase I-IV clinical trials following global standards. Fellows will assist on all aspects of managing trials including developing operating procedures, implementing data and quality measures, and training staff. Fellows' work will contribute to IDI's goal of being the premier service provider for patients with infectious diseases.
Richard is looking forward to mentoring the biostatisticians at the IDI and helping colleagues there to build internal capabilities for health economic analyses and decision making. On his return to Pfizer, he expects to have a better understanding of global markets, systems and process development, and to be better able to build capability with scarce resources.
Accordia Global Health Foundation is working to overcome the burden of infectious diseases by building health care capacity and strengthening academic medical institutions in Africa. Accordia does this through establishing Centers of Excellence for advancing and promoting the highest quality standards of infectious disease care through original research and health care workforce training. The Infectious Disease Institute (IDI) in Kampala, Uganda is Accordia's flagship program. Created via public-private partnership and multi-institutional collaboration, IDI serves as a model for sustainable, locally-owned, regional centers of excellence. IDI offers high quality training for health workers; research on best practices related to HIV in low resource settings; and advanced clinical services that support the development of new models of care.